| 1 |
|
Long-Term and Low-Dose Treatment with Cabergoline Induces Macroprolactinoma Shrinkage
|
Colao, A
|
Issued for the Endocrine Society by the Williams ＆ Wilkins Co
|
1980
|
|
|
|
| 2 |
|
Effect of Different Dopaminergic Agents in the Treatment of Acromegaly
|
Colao, A
|
Issued for the Endocrine Society by the Williams ＆ Wilkins Co
|
1980
|
|
|
|
| 3 |
|
Prediction of Efficacy of Octreotide Therapy in Patients with Acromegaly
|
Colao, A
|
Issued for the Endocrine Society by the Williams ＆ Wilkins Co
|
1980
|
|
|
|
| 4 |
|
Effect of Octreotide Pretreatment on Surgical Outcome in Acromegaly
|
Colao, A
|
Issued for the Endocrine Society by the Williams ＆ Wilkins Co
|
1980
|
|
|
|
| 5 |
|
Acromegaly
|
Colao, A
|
Issued for the Endocrine Society by the Williams ＆ Wilkins Co
|
1980
|
|
|
|
| 6 |
|
Prolactinomas Resistant to Standard Dopamine Agonists Respond to ChronicCabergoline Treatment
|
Colao, A
|
Issued for the Endocrine Society by the Williams ＆ Wilkins Co
|
1980
|
|
|
|
